In May 2015, the U.S. Food and Drug Administration (FDA) issued a warning that the diabetes medication Invokana may be linked to ketoacidosis, a life-threatening condition that causes the body to produce high levels of blood acids. Since this connection was uncovered, people who have taken Invokana have been bringing lawsuits against the manufacturers of the drug and other types of sodium-glucose cotransporter 2 (SGLT2) inhibitors used to control blood sugar in patients with type 2 diabetes. Studies indicate that between March 2013 and June 6, 2014 there have been at least 20 cases of diabetic ketoacidosis (DKA) in those who have used Invokana or other SGLT2 inhibitors.
If you or a loved one has suffered as a result of taking this dangerous drug, please contact Atkins and Markoff today. Our personal injury attorneys will work with you to ensure justice is served and those responsible for your injuries are held accountable. We have been keeping a close eye on the various Invokana lawsuits throughout the country and are prepared to fight for your rights today.
What is Invokana?
As mentioned, Invokana is a SGLT2 inhibitor that is designed to control blood sugar in patients who have been diagnosed with type 2 diabetes mellitus. Invokana and other similar drugs – such as Invokamet, Jardiance, Xigduo XR, Farxiga, and Glyxambi – works by increasing the removal of glucose from the kidneys. Marketed under license by Janssen, a division of Johnson & Johnson, Invokana is manufactured by Mitsubishi Tanabe Pharma. When used in conjunction with diet and exercise, Invokana is supposed to improve glycemic control and lower blood sugar in those adults suffering from type 2 diabetes. Type 2 diabetes is a serious condition that could lead to blindness, nerve damage, kidney failure, heart disease, and stroke if left untreated.
Invokana and Ketoacidosis
According to the FDA, DKA does not usually occur in patients with type 2 diabetes. This is an atypical symptom that has been linked to Invokana and could be very serious. The following are symptoms of DKA:
- Difficulty breathing
- Abdominal pain
Those who are taking Invokana and experience any of these symptoms should contact their doctor right away. Keep in mind that FDA warns people against stopping their diabetic medications without talking to their doctor first, which is why it is imperative for you to take action immediately.
The FDA believes that the onset of DKA symptoms in those taking Invokana was typically about two weeks, however, this could vary from patient to patients. If you have experienced life-threatening side effects or have incurred any damages as the result of taking Invokana, please contact Atkins & Markoff today. Our experienced Oklahoma personal injury lawyers are here for you and are ready to get to work on your case today.